Home » EDAP TMS Signs Ablatherm Contract With French Hospitals
EDAP TMS Signs Ablatherm Contract With French Hospitals
EDAP TMS announced the purchase of the first Ablatherm device by "La Mutualite Francaise" which is responsible for more than 2,000 public clinics in France. Starting with six sites throughout France, Ablatherm will be shared on a mobile basis, making the HIFU treatment available in France to a broader population of patients suffering from localized prostate cancer.
ArriveNet (http://press.arrivenet.com/bus/article.php/592875.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct